Journal of medical virologyHumansCytomegalovirus InfectionsMaleFemaleHematopoietic Stem Cell Transplantation
Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis.
Jung Soo Son, Eun-Jeong Jeong, Hyeon Jae Jo, Chan Mi Lee, Ja Min Byun, Chang Kyung Kang, Youngil Koh, Junshik Hong, Dong-Yeop Shin, Pyeong Gyun Choe, Wan Beom Park, Nam Joong Kim, Sung-Soo Yoon, Inho Kim
Published: 202510.1002/jmv.70736
Abstract
Cytomegalovirus (CMV) infection remains a major contributor to CMV-related and hematologic adverse outcomes in hematopoietic stem cell transplantation (HSCT) recipients. While letermovir has improved CMV prophylaxis strategies in this population, the…
Preview only. Read the full abstract at the source